Nephron Sc Inc

6 FDA enforcement actions

6 Total Recalls

0 Class I

6 Class II

0 Class III

Firm Details

Product Types: drug
States: SC

All Recalls

Class II: Risk 02/23/2023 drug

CGMP Deviations: Potential product carryover.
Class II: Risk 01/13/2023 drug

Short Fill
Class II: Risk 01/13/2023 drug

Short Fill
Class II: Risk 01/12/2023 drug

CGMP Deviations: potential for trace amounts of product carryover.
Class II: Risk 01/12/2023 drug

CGMP Deviations: potential for trace amounts of product carryover.
Class II: Risk 08/10/2022 drug

cGMP Deviations: deviations leading to potential cross-contamination.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.